How many studies have been conducted on Tesamorelin?

BiohacksAI has indexed 81 PubMed studies on Tesamorelin, including 21 randomized controlled trials (RCTs). 74% of studies involve human subjects.

What are the main research areas for Tesamorelin?

The primary research domains for Tesamorelin are 🧬 Hormones, 🔥 Metabolic, 🫁 Liver & Detox. This is based on analysis of 81 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Tesamorelin

a peptide; a stabilized analogue of the growth hormone releasing factor; aimed at reducing excess abdominal fat or VAT in lipodystrophy and HIV patients

81+ PubMed studies analyzed · 21 RCTs · Evidence Score: 57

Research Domains

Tesamorelin has been studied across 16 research domains including 🧬 Hormones, 🔥 Metabolic, 🫁 Liver & Detox, 🧠 Cognitive, ⏳ Longevity & Aging. The primary research focus is 🧬 Hormones with 75% of studies addressing this area.

Loading evidence profile...

This evidence profile for Tesamorelin is generated deterministically from 81 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.